Exchange: NASDAQ·Updated 12:54 PM EDT
PLRX logo

PLRX Pliant Therapeutics Inc

$1.12
$0.01
(0.89%)
Today
Reported EarningsAug 11
Mkt Cap$69.97M
Vol72,208.00

About PLRX

Pliant Therapeutics, Inc. engages in the discovery, development and commercialization of therapies for fibrotic diseases. It offers a product discovery engine. The company is pursuing drug development programs for a range of fibrotic diseases, focusing on tissue-specific integrin modulation and TGF-ß1 signaling inhibition. The company was founded by Bradley Backes, Bill De Grado, Hal Chapman, and Dean Sheppard in June 2015 and is headquartered in South San Francisco, CA.
32

Bearish Sentiment

How do you feel about PLRX?

Advertisement|Remove ads.